Home » Topics » BioWorld Science

BioWorld Science
RSS

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

May 13, 2021

Full-data analysis from 12-month treatment phase of ALTISSIMO study in wet AMD

May 13, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

ShanghaiTech University, Fudan University patent new PROTACs

May 13, 2021

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

May 13, 2021

New anti-HBV compounds identified at Sunshine Lake Pharma

May 13, 2021

ReViral synthesizes new benzodiazepine derivatives

May 13, 2021

Ono Pharmaceutical, Vanderbilt University present KCNT1/KCNK2 blockers

May 13, 2021

Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer

May 13, 2021

Phase I dose-escalation study tests combination immunotherapy with belapectin and pembrolizumab

May 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...